Expedition Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $115M

  • Investors
  • 14

Expedition Therapeutics General Information

Description

Developer of biotechnology therapies designed to treat serious inflammatory and respiratory diseases. The company offers novel therapeutic candidates for inflammatory and respiratory conditions, enabling healthcare professionals to access treatment options for patients with serious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2261 Market Street
  • Suite 10321
  • San Francisco, CA 94114
  • United States
Primary Industry
Biotechnology
Other Industries
Business/Productivity Software
Enterprise Systems (Healthcare)
Vertical(s)
Corporate Office
  • 2261 Market Street
  • Suite 10321
  • San Francisco, CA 94114
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Expedition Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 05-Aug-2026 $115M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) Completed Clinical Trials - Phase 1
To view Expedition Therapeutics’s complete valuation and funding history, request access »

Expedition Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A2
Series A1 44,424,088 $0.000010 8% $3.71 $3.71 1x $3.71 55.01%
To view Expedition Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Expedition Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Expedition Therapeutics Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adage Capital Management Hedge Fund Minority
Balyasny Asset Management Hedge Fund Minority
BVF Partners Hedge Fund Minority
Dawn Biopharma Corporation Minority
Forbion Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Expedition Therapeutics FAQs

  • When was Expedition Therapeutics founded?

    Expedition Therapeutics was founded in 2024.

  • Where is Expedition Therapeutics headquartered?

    Expedition Therapeutics is headquartered in San Francisco, CA.

  • What is the size of Expedition Therapeutics?

    Expedition Therapeutics has 3 total employees.

  • What industry is Expedition Therapeutics in?

    Expedition Therapeutics’s primary industry is Biotechnology.

  • Is Expedition Therapeutics a private or public company?

    Expedition Therapeutics is a Private company.

  • What is the current valuation of Expedition Therapeutics?

    The current valuation of Expedition Therapeutics is .

  • What is Expedition Therapeutics’s current revenue?

    The current revenue for Expedition Therapeutics is .

  • How much funding has Expedition Therapeutics raised over time?

    Expedition Therapeutics has raised $280M.

  • Who are Expedition Therapeutics’s investors?

    Adage Capital Management, Balyasny Asset Management, BVF Partners, Dawn Biopharma, and Forbion are 5 of 14 investors who have invested in Expedition Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process